MICROTECH CERAMICS LIMITED

Financial Health Score: F (Critical Condition)

Explanation: Microtech Ceramics Limited is in a state of severe financial distress, analogous to a patient in critical condition requiring life support. The company is deeply insolvent, with liabilities exceeding assets by over £2.3 million. Its cash reserves are dangerously low (£3,589), and it is suffering from chronic, compounding annual losses. The company is only surviving because its creditors—likely the corporate entities with significant control—are not calling in the debts. Without ongoing external financial transfusions, the business faces a high risk of administrative failure.

Key Vital Signs

• Net Assets / Shareholders' Funds: -£2,345,135 (2025)
  • Interpretation: The "blood pressure" of the company is dangerously low and negative. Net assets have deteriorated significantly from -£1,656,856 in 2024. This indicates that the company owes far more than it owns, a classic symptom of severe insolvency.
• Cash at Bank: £3,589 (2025)
  • Interpretation: The company is suffering from severe financial "anemia." Cash has plummeted from £98,700 in 2014 and £41,495 as recently as 2023. With barely enough cash to cover a few weeks of operations, liquidity is critically compromised.
• Current Liabilities: £2,643,585 (2025)
  • Interpretation: There is a massive blockage in the company's financial arteries. Current liabilities have ballooned by over £800k from the previous year. Given the company's size and minimal staff (3 employees), this debt is almost certainly inter-company loans from its corporate shareholders (Kero Limited, Belton Massey Ltd, and Imperial Innovations Businesses LLP) funding ongoing Research & Development.
• Profit & Loss Reserve: -£3,411,132 (2025)
  • Interpretation: This represents chronic internal bleeding. The accumulated losses have worsened by nearly £700k over the last year, indicating that the business model is not yet self-sustaining and continues to burn through capital.

Diagnosis

Symptoms Analysis: The financial data reveals a company that is technically insolvent but kept alive by the life support of its corporate owners. Microtech Ceramics Limited operates in the R&D sector (SIC 72190), which inherently involves burning cash before commercialization. However, the scale of the accumulated losses (-£3.4M P&L reserve) versus the share premium (£1M) shows a massive disconnect between the capital raised and the value generated.

The most alarming symptom is the drastic drop in cash alongside a massive increase in current liabilities. Interestingly, 2025 saw a significant jump in debtors (from £85k to £153k) and tangible fixed assets (from £42k to £129k). This suggests the company may have recently invested in new equipment or shifted its business model, but this expansion was funded entirely by debt, worsening its net liability position.

Prognosis: The short-term prognosis is stable only if the PSCs (Persons with Significant Control) continue to support the business and waive their right to demand repayment. If these creditors were to demand repayment, the company would immediately face a liquidity crisis and likely administration. Long-term survival depends entirely on the R&D efforts transitioning from a cost center to a revenue-generating one, or securing further equity investment to clear the debt.

Recommendations

1. Financial Surgery (Capital Restructuring): The most urgent requirement is a balance sheet restructure. The corporate shareholders should formally convert a substantial portion of their inter-company loans into equity. This would reduce the current liabilities, improve net assets, and relieve the immediate pressure on cash flow, making the company appear healthier to any external credit providers.
2. Cash Flow Transfusion: With only £3,589 in the bank, the company is dangerously exposed to unexpected costs. The directors must secure immediate, ring-fenced funding or a formal overdraft facility to provide a buffer for day-to-day operations.
3. Going Concern Assessment: The directors must rigorously assess the "going concern" status. Since the company relies entirely on creditor forbearance, formal written guarantees from the parent/PSC entities confirming ongoing financial support for at least 12 months must be obtained and documented to satisfy accounting standards.
4. Commercial Rehabilitation: The R&D focus must rapidly shift toward commercialization. With only 3 employees, the burn rate is relatively low, but it is still unsustainable without revenue. A clear roadmap to monetizing the intellectual property or securing grant funding is critical to stop the ongoing P&L hemorrhage.